Found: 17
Select item for more details and to access through your institution.
AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL). REAL‐WORLD REPORT OF POLISH LYMPHOMA RESEARCH GROUP.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 691, doi. 10.1002/hon.3165_544
- By:
- Publication type:
- Article
CHARACTERISTICS AND TREATMENT OUTCOMES OF AGGRESSIVE HIGH GRADE B CELL LYMPHOMA WITH MYC AND BCL 6 REARRANGEMENTS.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 651, doi. 10.1002/hon.3165_501
- By:
- Publication type:
- Article
A phase 2 study of zilovertamab vedotin as monotherapy or in combination in patients (pts) with aggressive and indolent B‐cell malignancies: waveLINE‐006.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 564, doi. 10.1002/hon.3164_422
- By:
- Publication type:
- Article
Outpatient treatment with 2 cycles of Bendamustine, Gemcitabine and Dexamethasone is Effective and Safe in r/r Hodgkin Lymphoma—Polish Lymphoma Research Group Study.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 364, doi. 10.1002/hon.3164_262
- By:
- Publication type:
- Article
WAVELINE‐004: OPEN‐LABEL, PHASE 2 STUDY OF ZILOVERTAMAB VEDOTIN (MK‐2140) IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL).
- Published in:
- Hematological Oncology, 2023, v. 41, p. 208, doi. 10.1002/hon.3163_136
- By:
- Publication type:
- Article
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE ERA OF NOVEL THERAPIES‐ A RETROSPECTIVE ANALYSIS BY POLISH LYMPHOMA RESEARCH GROUP.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.24_2881
- By:
- Publication type:
- Article
HEALTH‐RELATED QUALITY OF LIFE AMONG PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL) IN A PHASE 3 STUDY OF PEMBROLIZUMAB VERSUS BRENTUXIMAB VEDOTIN.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.105_2880
- By:
- Publication type:
- Article
PRIMARY BREAST DIFFUSE LARGE B‐CELL LYMPHOMA. CLINICAL FEATURES AND OUTCOME IN 55 PATIENTS. POLISH LYMPHOMA RESEARCH GROUP STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 450, doi. 10.1002/hon.126_2631
- By:
- Publication type:
- Article
OFATUMUMAB WITH IVAC FOR DLBCL PATIENTS WHO FAILED R‐CHOP AND WERE NOT CANDIDATES FOR HIGH‐DOSE THERAPY AND ASCT ‐ PHASE 2 TRIAL OF THE POLISH LYMPHOMA RESEARCH GROUP (PLRG‐8).
- Published in:
- Hematological Oncology, 2019, v. 37, p. 436, doi. 10.1002/hon.111_2631
- By:
- Publication type:
- Article
OUTCOME OF PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA WHO FAILED TO PROCEED TO OR RELAPSED AFTER HIGH DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 435, doi. 10.1002/hon.109_2631
- By:
- Publication type:
- Article
PRIMARY BREAST DIFFUSE LARGE B‐CELL LYMPHOMA. CLINICAL FEATURES AND OUTCOME IN 55 PATIENTS. POLISH LYMPHOMA RESEARCH GROUP STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 450, doi. 10.1002/hon.126_2631
- By:
- Publication type:
- Article
OFATUMUMAB WITH IVAC FOR DLBCL PATIENTS WHO FAILED R‐CHOP AND WERE NOT CANDIDATES FOR HIGH‐DOSE THERAPY AND ASCT ‐ PHASE 2 TRIAL OF THE POLISH LYMPHOMA RESEARCH GROUP (PLRG‐8).
- Published in:
- Hematological Oncology, 2019, v. 37, p. 436, doi. 10.1002/hon.111_2631
- By:
- Publication type:
- Article
OUTCOME OF PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA WHO FAILED TO PROCEED TO OR RELAPSED AFTER HIGH DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 435, doi. 10.1002/hon.109_2631
- By:
- Publication type:
- Article
THE RISK OF TRANSFORMATION OF FOLLICULAR LYMPHOMA 'TRANSFORMED' BY RITUXIMAB: THE ARISTOTLE STUDY PROMOTED BY THE EUROPEAN LYMPHOMA INSTITUTE.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 115, doi. 10.1002/hon.2437_104
- By:
- Publication type:
- Article
R-CHOP is not effective regimen in CD5(+) DLBCL diagnosed by flow-cytometry/immunohistochemistry, karyotype and BCL2/ BCL6 status and expression.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 333, doi. 10.1002/hon.2439_78
- By:
- Publication type:
- Article
R- DAEPOCH as a first line treatment for high grade B cell lymphoma and diffuse large B cell lymphoma with unfavorable features.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 335, doi. 10.1002/hon.2439_81
- By:
- Publication type:
- Article
Presence of t(14;18) positive cells in blood and bone marrow does not predict outcome in follicular lymphoma.
- Published in:
- Medical Oncology, 2009, v. 26, n. 1, p. 16, doi. 10.1007/s12032-008-9071-1
- By:
- Publication type:
- Article